Direct Activation of the ATM Protein Kinase by the Mre11/Rad50/Nbs1 Complex

Science

Volumn 304, Issue 5667, 2004, Pages 93-96

  Lee, Ji Hoon ^a   Paull, Tanya T ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; CELLS; DNA; MUTAGENESIS;

CELLULAR RESPONSES; PHOSPHORYLATION;

ENZYMES;

ATM PROTEIN; MRE11 PROTEIN; NIBRIN; PROTEIN; PROTEIN KINASE; RAD50 PROTEIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; CHECKPOINT KINASE 2; DNA; DNA BINDING PROTEIN; H2AFX PROTEIN, HUMAN; HISTONE; MRE11A PROTEIN, HUMAN; NBS1 PROTEIN, HUMAN; NUCLEAR PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; RAD50 PROTEIN, HUMAN; RECOMBINANT PROTEIN; TUMOR SUPPRESSOR PROTEIN;

PROTEIN;

ARTICLE; COMPLEX FORMATION; DNA STRAND BREAKAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ATAXIA TELANGIECTASIA; GENETICS; METABOLISM; MISSENSE MUTATION; MUTATION; PHOSPHORYLATION;

ATAXIA; ATAXIA TELANGIECTASIA;

ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; DNA; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; ENZYME ACTIVATION; HISTONES; HUMANS; MUTATION; MUTATION, MISSENSE; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 1842431822     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1091496     Document Type: Article

References (31)

1. Y. Shiloh, Nature Rev. Cancer 3, 155 (2003).
2. J. P. Carney et al., Cell 93, 477 (1998).
3. M. Gatei et al., Nature Genet. 25, 115 (2000).
4. D. S. Lim et al., Nature 404, 613 (2000).
5. X. Wu et al., Nature 405, 477 (2000).
6. S. Zhao et al., Nature 405, 473 (2000).
7. S. T. Kim, B. Xu, M. B. Kastan, Genes Dev. 16, 560 (2002).
8. J. H. Lee et al., Mol. Cancer Res. 1, 674 (2003).
9. R. Varon et al., Cell 93, 467 (1998).
10. G. Buscemi et al., Mol. Cell. Biol. 21, 5214 (2001).
11. P. M. Girard, E. Riballo, A. C. Begg, A. Waugh, P. A. Jeggo, Oncogene 21, 4191 (2002).
12. P. T. Yazdi et al., Genes Dev. 16, 571 (2002).
13. K. Nakanishi et al., Nature Cell Biol. 4, 913 (2002).
14. M. Gatei et al., J. Biol. Chem. 278, 14806 (2003).
15. C. H. McGowan, Bioessays 24, 502 (2002).
16. J.-H. Lee, T. T. Paull, unpublished data.
17. G. S. Stewart et al., Cell 99, 577 (1999).
18. J.-H. Lee et al., J. Biol. Chem. 278, 45171 (2003).
19. R. S. Maser, R. Zinkei, J. H. Petrini, Nature. Genet. 27, 417 (2001).
20. J. H. Petrini, Curr. Opin. Cell Biol. 12, 293 (2000).
21. T. Uziel et al., EMBO J. 22, 5612 (2003).
22. R. A. Gatti, A. Tward, P. Concannon, Mol. Genet. Metab. 68, 419 (1999).
23. K. Spring et al., Nature Genet. 32, 185 (2002).
24. C. E. Canman et al., Science 281, 1677 (1998).
25. S. Y. Shieh, M. Ikeda, Y. Taya, C. Prives, Cell 91, 325 (1997).
26. J. D. Sillciano et al., Genes Dev. 11, 3471 (1997).
27. E. P. Rogakou, D. R. Pilch, A. H. Orr, V. S. Ivanova, W. M. Bonner, J. Biol. Chem. 273, 5858 (1998).
28. T. Paull et al., Curr. Biol. 10, 886 (2000).
29. Materials and methods are available as supporting material on Science Online.
30. C. J. Bakkenist, M. B. Kastan, Nature 421, 499 (2003).
31. We thank M. Kastan, J. Huibregtse, and J. Chung for expression constructs, and J. Gautier for comments on the manuscript. Supported by the NIH (CA94008) and the Kimmel Cancer Research Foundation.